Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Long-Term Deferred Tax (2025 - 2026)

BioScience Health Innovations has reported Long-Term Deferred Tax over the past 2 years, most recently at $2069.0 for Q1 2026.

  • Quarterly Long-Term Deferred Tax changed N/A to $2069.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2069.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $2069.0 for FY2025, N/A changed from the prior year.
  • Long-Term Deferred Tax was $2069.0 for Q1 2026 at BioScience Health Innovations, roughly flat from $2069.0 in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $2069.0 in Q4 2025 and troughed at $2069.0 in Q4 2025.